Prevalence and predictor factors of severe venous obstruction after cardiovascular electronic device implantation
- PMID: 26705557
- DOI: 10.1093/europace/euv391
Prevalence and predictor factors of severe venous obstruction after cardiovascular electronic device implantation
Abstract
Aims: Despite not being uncommon, limited evidence exists about predisposing factors for venous obstruction in patients with implantable electronic devices. We aimed to assess the prevalence of severe venous obstruction in patients with intravenous devices and identify predictor factors.
Methods and results: A total of 184 patients underwent venography to detect venous obstruction associated with the inserted lead. Vessel obstruction was graded as venous occlusion (complete flow interruption), severe obstruction (narrowing >90%), or mild-moderate obstruction (narrowing 50-90%). Severe venous obstruction/occlusion prevalence was 11.4% (n = 21) and was always asymptomatic. Collateral circulation was found in 80.9% of patients with severe obstruction/occlusion. Twelve patients (6.5%) had 3 leads. The rates of patients with secondary prevention of sudden cardiac death as indication for implantable devices and of those of patients with 3 leads were significantly greater in the group with severe obstruction/occlusion than in the non-severe obstruction/occlusion group (respectively, P = 0.004 and P = 0.03). Logistic analysis adjusted for venous thromboembolic risk factors confirmed that secondary prevention of sudden cardiac death as indication for implantable devices [odds ratio (OR), 7.1; 95% confidence interval (CI): 1.4-35.3; P = 0.017] and the presence of 3 leads (OR, 8.5; 95% CI: 1.75-41.35; P = 0.008) were predictors of severe obstruction/occlusion.
Conclusion: In patients with implantable devices, severe venous obstruction prevalence is not negligible and the lack of symptoms does not exclude it. The presence of three leads and sudden cardiac death as indication for implantable devices seem to be associated with the presence of severe venous obstruction/occlusion.
Keywords: Cardiac resynchronization therapy; Implantable cardioverter-defibrillator; Pacemaker; Predictor factor; Venous obstruction.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com.
Similar articles
-
Usefulness of preoperative venography in patients with cardiac implantable electronic devices submitted to lead replacement or device upgrade procedures.Arq Bras Cardiol. 2018 Nov;111(5):686-696. doi: 10.5935/abc.20180164. Epub 2018 Sep 21. Arq Bras Cardiol. 2018. PMID: 30281686 Free PMC article.
-
Upper extremity deep venous thrombosis and stenosis after implantation of pacemakers and defibrillators; A prospective study.Rom J Intern Med. 2017 Sep 26;55(3):139-144. doi: 10.1515/rjim-2017-0018. Rom J Intern Med. 2017. PMID: 28432849
-
Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade.Europace. 2007 May;9(5):328-32. doi: 10.1093/europace/eum019. Epub 2007 Mar 16. Europace. 2007. PMID: 17369270
-
Venous thrombosis and stenosis after implantation of pacemakers and defibrillators.J Interv Card Electrophysiol. 2005 Jun;13(1):9-19. doi: 10.1007/s10840-005-1140-1. J Interv Card Electrophysiol. 2005. PMID: 15976973 Review.
-
Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.Med Clin North Am. 2015 Jul;99(4):795-804. doi: 10.1016/j.mcna.2015.02.008. Med Clin North Am. 2015. PMID: 26042883 Review.
Cited by
-
Should they stay, or should they go: Do we need to remove the old cardiac implantable electronic device if a new system is required on the contralateral side?Heart Rhythm O2. 2022 Feb 13;3(2):169-175. doi: 10.1016/j.hroo.2022.02.005. eCollection 2022 Apr. Heart Rhythm O2. 2022. PMID: 35496451 Free PMC article.
-
Lead failure in transvenous implantable cardioverter defibrillator: a new opportunity for an effective management.Clin Case Rep. 2018 Jul 7;6(9):1668-1670. doi: 10.1002/ccr3.1533. eCollection 2018 Sep. Clin Case Rep. 2018. PMID: 30214738 Free PMC article.
-
The usefulness of balloon occlusive left ventricular lead delivery in combination with the quadripolar active fixation lead for a patient with complex coronary venous morphology.J Cardiol Cases. 2021 Oct 20;25(4):225-228. doi: 10.1016/j.jccase.2021.09.013. eCollection 2022 Apr. J Cardiol Cases. 2021. PMID: 35911072 Free PMC article.
-
Balloon venoplasty opens the road for an implantable defibrillator patient with complex stenosis.Clin Case Rep. 2017 May 16;5(7):1067-1071. doi: 10.1002/ccr3.1002. eCollection 2017 Jul. Clin Case Rep. 2017. PMID: 28680596 Free PMC article.
-
State of the art: leadless ventricular pacing : A national expert consensus of the Austrian Society of Cardiology.J Interv Card Electrophysiol. 2020 Jan;57(1):27-37. doi: 10.1007/s10840-019-00680-2. Epub 2019 Dec 20. J Interv Card Electrophysiol. 2020. PMID: 31863250 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical